GoodRx Holdings (GDRX) Non Operating Income (2019 - 2026)

GoodRx Holdings has disclosed Non Operating Income across 8 years of filings, most recently posting -$8.2 million for Q2 2026.

• In Q2 2026, Non Operating Income fell 12.91% year-over-year to -$8.2 million; the TTM figure through Jun 2026 stood at -$33.5 million (down 1.62% YoY), while the FY2025 annual figure was -$31.0 million, up 9.98% from the prior year.
• Non Operating Income came in at -$8.2 million for Q2 2026 at GoodRx Holdings, up from -$8.4 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of -$5.8 million in Q1 2022 to a low of -$12.3 million in Q3 2024.
• Average Non Operating Income over 5 years is -$7.5 million, with a median of -$7.2 million recorded in 2024.
• Year-over-year, Non Operating Income sank 48.65% in 2024 and soared 30.7% in 2025.
• Over 5 years, Non Operating Income stood at -$6.5 million in 2022, then increased by 2.08% to -$6.3 million in 2023, then retreated by 6.68% to -$6.8 million in 2024, then slipped by 25.39% to -$8.5 million in 2025, then advanced by 3.82% to -$8.2 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$8.2 million in Q2 2026, -$8.4 million in Q1 2026, and -$8.5 million in Q4 2025.